Nicholas Lydon, Director at ANAPTYSBIO INC (ANAB), sold 61,750 shares at $87.46 ($5.4M) on 2018-04-16, disclosed to the SEC on 2018-04-18.
Open-market sale of $5.4M ANAB by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $84.18 | 2,600 | $219K | 4.1% |
| 2 | $84.18 | 2,600 | $219K | 4.1% |
| 3 | $85.11 | 10,310 | $877K | 16.4% |
| 4 | $85.11 | 10,310 | $877K | 16.4% |
| 5 | $86.15 | 1,390 | $120K | 2.2% |
| 6 | $86.15 | 1,390 |
| $120K |
| 2.2% |
| 7 | $87.46 | 9,425 | $824K | 15.4% |
| 8 | $87.46 | 9,425 | $824K | 15.4% |
| 9 | $88.30 | 4,250 | $375K | 7.0% |
| 10 | $89.42 | 2,803 | $251K | 4.7% |
| 11 | $89.42 | 2,803 | $251K | 4.7% |
| 12 | $90.26 | 2,222 | $201K | 3.7% |
| 13 | $90.26 | 2,222 | $201K | 3.7% |
| Total | $86.78 avg | 61,750 | $5.4M | 100% |
| Filing → |
| BPMC | SELL | 2020-07-08 | $4.1M | — | Filing → |
| BPMC | SELL | 2020-07-06 | $661K | — | Filing → |
| BPMC | SELL | 2020-06-25 | $32K | — | Filing → |